JD Health Sets 13 Aug 2026 Board Meeting to Approve H1 2026 Results and Discuss Interim Dividend

Bulletin Express07-31

JD Health announced that its board of directors will convene on 13 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend for shareholders.

Management will host an earnings call on the same day at 17:00 (Beijing/Hong Kong Time) to present the half-year performance and respond to investor questions. Dial-in access will be available for participants in Mainland China, Hong Kong, the United States and Singapore, with separate passcodes for Mandarin and English channels.

The board currently comprises one executive director, one non-executive director and five independent non-executive directors. The announcement was issued in Hong Kong on 31 July 2026 and signed by Executive Director Mr. Dong Cao.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment